138 related articles for article (PubMed ID: 12671413)
1. Empiric esomeprazole in the treatment of laryngopharyngeal reflux.
DelGaudio JM; Waring JP
Laryngoscope; 2003 Apr; 113(4):598-601. PubMed ID: 12671413
[TBL] [Abstract][Full Text] [Related]
2. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
3. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
4. Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Belafsky PC; Postma GN; Koufman JA
Laryngoscope; 2001 Jun; 111(6):979-81. PubMed ID: 11404607
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.
Reichel O; Dressel H; Wiederänders K; Issing WJ
Otolaryngol Head Neck Surg; 2008 Sep; 139(3):414-20. PubMed ID: 18722223
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
[TBL] [Abstract][Full Text] [Related]
7. Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux.
Issing WJ; Karkos PD; Perreas K; Folwaczny C; Reichel O
J Laryngol Otol; 2004 Nov; 118(11):845-8. PubMed ID: 15638969
[TBL] [Abstract][Full Text] [Related]
8. Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome.
Lien HC; Wang CC; Liang WM; Sung FC; Hsu JY; Yeh HZ; Chong K; Chang CS
Laryngoscope; 2013 Jun; 123(6):1483-9. PubMed ID: 23553459
[TBL] [Abstract][Full Text] [Related]
9. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
[TBL] [Abstract][Full Text] [Related]
10. [Repeated dual-probe pH monitoring as a diagnostic tool to control therapy for laryngopharyngeal reflux].
Reichel O; Durst F; Rasp G; Berghaus A
HNO; 2007 Oct; 55(10):798-803. PubMed ID: 17431571
[TBL] [Abstract][Full Text] [Related]
11. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
Gold BD; Gunasekaran T; Tolia V; Wetzler G; Conter H; Traxler B; Illueca M
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):520-9. PubMed ID: 18030228
[TBL] [Abstract][Full Text] [Related]
12. A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.
Johnson DA; Stacy T; Ryan M; Wootton T; Willis J; Hornbuckle K; Brooks W; Doviak M
Aliment Pharmacol Ther; 2005 Jul; 22(2):129-34. PubMed ID: 16011671
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
[TBL] [Abstract][Full Text] [Related]
14. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
15. Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux.
Qadeer MA; Swoger J; Milstein C; Hicks DM; Ponsky J; Richter JE; Abelson TI; Vaezi MF
Laryngoscope; 2005 Nov; 115(11):1947-52. PubMed ID: 16319603
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of laryngopharyngeal reflux disease with digital imaging.
Beaver ME; Stasney CR; Weitzel E; Stewart MG; Donovan DT; Parke RB; Rodriguez M
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):103-8. PubMed ID: 12574767
[TBL] [Abstract][Full Text] [Related]
17. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.
Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):530-7. PubMed ID: 18030229
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
[TBL] [Abstract][Full Text] [Related]
20. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
